Session Spotlight: Account for the Government Pricing and Contracting Impact on Gross-to-Net Calculations

As the largest healthcare provider to the American population, the US government has a significant impact on pharmaceutical company financials. With Medicaid expansion continuing into 2014, this impact is only going to grow. Manufacturers must calculate prices for each product, along with the reimbursement rate on each prescription. These rebates make GTN calculations a time-consuming endeavor for finance divisions, so what is the best way to proceed?

Session: Account for the Government Pricing and Contracting Impact on Gross-to-Net Calculations

Speaker: Jennifer Norton, Senior Director, Pricing & Contract Administration - Managed Markets, Vertex Pharmaceuticals , Inc.

The US Government is the largest healthcare provider to the American population and therefore has a significant impact on pharmaceutical company financials. Each day we hear of another state’s decision whether or not to expand Medicaid, as is their option. As some states decide to expand, the government’s impact on company financials will only continue to grow. Government reimbursement and rebates have a direct impact on GTN calculations. In this session, executives from Vertex Pharmaceuticals will discuss how government pricing and contracting affects GTN and the operational challenges that arise that affect that calculation.

Want to learn more? Download our brochure.

The Gross-to-Net Accounting Forum takes place June 17-18 in Boston, MA. As a reader of this blog you'll receive 15% off the standard rate by using code XP1811BLOG when you register. We look forward to seeing you this June!